The stock of Tristel Plc (LON:TSTL) hit a new 52-week high and has GBX 190.08 target or 8.00% above today’s GBX 176.00 share price. The 7 months bullish chart indicates low risk for the GBX 72.90 million company. The 1-year high was reported on Nov, 29 by Barchart.com. If the GBX 190.08 price target is reached, the company will be worth GBX 5.83M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. The stock increased 2.92% or GBX 5 on November 29, hitting GBX 176. About 188,467 shares traded hands or 227.99% up from the average. Tristel Plc (LON:TSTL) has risen 45.53% since May 2, 2016 and is uptrending. It has outperformed by 40.27% the S&P500.
More recent Tristel Plc (LON:TSTL) news were published by: Uk.Finance.Yahoo.com which released: “-LSE Ticker: 07RVT9/ISIN: GB00B07RVT99” on March 29, 2014. Also Fool.Co.Uk published the news titled: “3 AIM Stocks For The Next 20 Years: ASOS plc, Tristel plc & OMG plc” on June 22, 2015. Fool.Co.Uk‘s news article titled: “Why I’ve Shunned GlaxoSmithKline plc & AstraZeneca plc But Bought Bioventix …” with publication date: October 17, 2015 was also an interesting one.
Tristel Plc is a United Kingdom-based maker of infection prevention and contamination control products. The company has a market cap of 72.90 million GBP. The Company’s technology is a chlorine dioxide formulation. It has a 37.19 P/E ratio. The Firm operates through three divisions: Human Healthcare, Animal Healthcare and Contamination Control.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.